©bongkarn thanyakij via Canva.com
Webinar on Batch Production Record, Device History Record Review and Quality Assessment
This Webinar is over| Date | Jun 10, 2014 |
| Time | 12:00 PM EDT |
| Cost | $195.00 |
|
Online
|
Overview:
Written procedures are to be established and followed for a time efficient and clear evidence of the quality related elements during the review and approval for release, including packaging and labeling, to determine compliance of the intermediates (FDA definition) and/or finished product with established specifications before a batch can be released for distribution.
BPRs, DHRs and laboratory control records for critical process steps are to be reviewed and approved by the quality unit(s) before a finished product batch is released for distribution. Production and laboratory control records for earlier, non-critical process steps may be reviewed by qualified production personnel or other units following procedures approved by the quality unit(s).
All incidents or deviations, investigation, and OOS, OOT, OOL reports should be reviewed to ensure there is no product quality impact by providing technically written sound scientific rationale for the assessment and conclusion as part of the batch record review before the batch is released.
Why Should You Attend:
A vast majority of the current industry deficiencies which have led to isolated 483s, Warning Letters and Consent Decrees are the result of deficient technical documentation of the production processes for both injectables, devices and solid dosages.
Areas Covered in the Session:
GlobalCompliancePanel
USA Phone:800-447-9407
webinars@globalcompliancepanel.com
http://www.globalcompliancepanel.com
Event Link - http://bit.ly/1jp92NF
Written procedures are to be established and followed for a time efficient and clear evidence of the quality related elements during the review and approval for release, including packaging and labeling, to determine compliance of the intermediates (FDA definition) and/or finished product with established specifications before a batch can be released for distribution.
BPRs, DHRs and laboratory control records for critical process steps are to be reviewed and approved by the quality unit(s) before a finished product batch is released for distribution. Production and laboratory control records for earlier, non-critical process steps may be reviewed by qualified production personnel or other units following procedures approved by the quality unit(s).
All incidents or deviations, investigation, and OOS, OOT, OOL reports should be reviewed to ensure there is no product quality impact by providing technically written sound scientific rationale for the assessment and conclusion as part of the batch record review before the batch is released.
Why Should You Attend:
A vast majority of the current industry deficiencies which have led to isolated 483s, Warning Letters and Consent Decrees are the result of deficient technical documentation of the production processes for both injectables, devices and solid dosages.
Areas Covered in the Session:
- Generation of BPRs, DHRs and SOPs to provide technically written instruction sets to eliminate operator errors. Training is NOT the primary means of generating and error free operation.
- Production and In-Process Controls
- Inspection, Packaging and Identification Labeling of Finished Products and Intermediates
- Responsibilities for Production Activities
- Data selection and entry into the statistical tracking from the BPR and DHR
- Incident / Deviation Tracking along with Customer Complaints and CAPA changes
- Annual Reports
- Quality
- Documentation Personnel
GlobalCompliancePanel
USA Phone:800-447-9407
webinars@globalcompliancepanel.com
http://www.globalcompliancepanel.com
Event Link - http://bit.ly/1jp92NF
Create your own event
Turn your passion into a business.
Turn your passion into a business.